Amicus Therapeutics Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include Sanofi Genzyme, PhaseBio Pharmaceuticals, NIOX and Tricida.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. |  NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ||
Founding Date | Founding Date 2002 | Founding Date 1981 | Founding Date 2002 | Founding Date 2006 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Malvern, US HQ | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations South San Francisco, US HQ |
Employees | Employees 58415% increase | Employees 9,9041% decrease | Employees 22 | Employees 92 | Employees 11914% increase |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $528.3m (FY, 2024) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $10.8m (FY, 2021) | Revenue (est.) £17k (FY, 2016) | Revenue (est.) N/A |
Net income | Net income ($56.1m) (FY, 2024) | Net income N/A | Net income ($131.1m) (FY, 2021) | Net income £17k (FY, 2016) | Net income ($176.6m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 88m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised $ 157m |
For sources of this data, please see the company profile
View Company Profiles
Sanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyPhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View companyNIOX
HQ
Morrisville, US
Employees
92
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company